Objective: Progesterone (P 4 ) has been clinically shown to prevent the recurrence of preterm birth. The mechanism(s) of action is unclear, but may involve modulation of the immunologic inflammatory response of the lower genital tract. We evaluated the effects of P 4 on interleukin-8 (IL-8) production by vaginal and cervical epithelial cells stimulated with bacterial species that are commonly associated with preterm birth. Methods: Vaginal and endocervical epithelial cells were incubated with up to 10,000 ng/mL P 4 overnight and stimulated with heat-killed Escherichia coli, Gardnerella vaginalis, or Ureaplasma urealyticum. Concentrations of IL-8 in conditioned medium were quantified by ELISA and viability of the cell cultures was measured by the reduction of a tetrazolium salt. Results: E. coli, G. vaginalis and U. urealyticum-stimulated IL-8 production for both cell lines. P 4 inhibited basal and bacteria-stimulated IL-8 production for vaginal epithelial cells but enhanced IL-8 production by endocervi- Conclusions: P 4 inhibits IL-8 production by vaginal epithelial cells stimulated with pathogens associated with preterm birth, possibly by reducing the number of viable cells or by inhibiting their proliferation. Although P 4 also reduces proliferation of endocervical cells it also increases their production of IL-8.
Introduction
Supplemental progesterone or progestin (P 4 ) has been shown to prevent recurrent preterm birth in several clinical trials w6, 19, 22x, however, the mechanism by which P 4 functions to prevent preterm birth remains unclear. Two recent studies have suggested that supplemental P 4 via vaginal suppositories prevents preterm birth in women with a short cervix w7, 13x and may also improve neonatal outcomes by reducing both admissions and lengths of stay at the neonatal intensive care unit w7x. In fact, P 4 had no significant effect on preterm birth in women with cervical lengths )28 mm. These studies suggest that the lower genital tract may be a target tissue for this hormone.
Many spontaneous preterm births are thought to be the end result of infections that ascend from the vagina through the cervix and become established in the upper genital tract. Bacterial products such as lipopolysaccharide (LPS) increase interleukin (IL)-8 production by cervical cells w29x. Aberrantly high concentrations of IL-8 in cervical-vaginal fluids have previously been correlated with preterm birth and chorioamnionitis w17x and both IL-8 and LPS have been shown to induce cervical ripening in animal models w5, 8, 9x. Premature cervical ripening could potentially permit bacteria to ascend into the upper genital tract where they can stimulate a preterm labor response. We therefore hypothesized that P 4 may prevent preterm birth by inhibiting bacteria-stimulated IL-8 production by cells of the lower genital tract. To test the biologic principle underlying this hypothesis, we used an in vitro model to test whether P 4 can alter IL-8 production by vaginal and endocervical cells exposed to bacterial pathogens commonly associated with infection-mediated preterm birth.
Materials and methods

Cell lines and bacterial cultures
Vaginal (VK2E6E7) and endocervical epithelial cells (ENDE6E7) were purchased from ATCC (Manassas, VA) for utilization in this experiment. These cell lines were produced from primary cultures isolated from non-pregnant subjects and immortalized by in vitro infection with human papilloma virus 16 and retain many characteristics of primary cells in terms of keratin expression w10x. Therefore, the responses of these cells are probably more physiological than other cell lines. Cells were propagated in keratinocyte serum-free (KSM) medium and split at 70-90% confluence by trypsinization. Stock reference cultures of Escherichia coli, Gardnerella vaginalis, Ureaplasma urealyticum (U. urealyticum serotype 1-now reclassified as U. parvum) were also purchased from ATCC. E. coli and G. vaginalis were cultivated as directed. U. urealyticum was cultivated in beef heart infusionq20% horse serumq10% Yeast extract dialysateq1 g/L ureaq20 mg/L phenol red. Organisms were harvested by centrifugation at 10,000 g and re-suspended in KSFM or RPMI 1640. The number of colony forming U/mL was then determined for E. coli or G. vaginalis by plating serial dilutions on the appropriate agar. Re-suspended cultures of U. urealyticum were quantified by measuring the color changing units (CCU), defined as the lowest 10-fold dilution that causes a color change (indicating growth) in the broth above. Bacteria were heat-killed by heating at 808C for 1 h and aliquots of the heat-killed bacteria were stored at -708C until use. This is a standard method of preparing bacteria for in vitro experiments to test cellular immune responses to bacterial components (live bacteria divide rapidly and would quickly overgrow the mammalian cells in culture).
Cell cultures
Freshly split cells (diluted 1:4 after trypsinization) were plated on 96-well plates in 160 mL medium and permitted to adhere overnight in a humidified incubator at 378C in a 5% CO 2 (v/v) atmosphere. P 4 treatments were then added to final concentration (0-10,000 ng/mL) in a volume of 20 mL KSMq10% fetal bovine serumq1% Dimethyl sulfoxide and cultures were incubated overnight as described above. Cells were then stimulated by adding heat-killed bacteria or an equivalent volume (20 mL) of vehicle and returned to the incubator for a final overnight incubation. A harvest of 100 mL of the conditioned medium was stored at -708C until assay for IL-8 by ELISA using reagents purchased from R and D systems (Minneapolis, MN). Potential effects of P 4 on number of viable cells was evaluated using the MTT assay as previously described w25x. Briefly, 20 mL tetrazolium salt (5 mg/mL) was incubated for 2 h at 378C. Formosan crystals formed by live cells were then dissolved by adding 100 mL 10% SDSq0.01 M HCl to each well and incubating the plate at 378C overnight. Optical density at 570 and 690 nm was quantified on a microplate spectrophotometer and data are expressed as OD , which is directly proportional to the relative number of live cells.
Statistical analyses
Data were analyzed using the general linear models procedure of SAS (SAS Institute, Cary, NC) for a randomized block design. Effects due to experiment were considered random and all others fixed. Results are reported as least-square means with accompanying asymptotic standard errors. Data from each experiment were evaluated for deviations from the assumptions of least-squares techniques (normality, equality, and independence of errors). When violations of the assumptions of ANOVA were detected, data were transformed using the Box-Cox algorithm w23x. Analyses from the transformed data were used for hypothesis testing (P-values). All data presented are from the untransformed dataset for clarity of presentation. IL-8 concentrations were not adjusted for confounding by viability of the cell cultures due to the possibility that any observed changes in IL-8 production may be caused by changes in the number of viable cells and would, therefore, violate the assumptions of analysis of covariance. significantly decreased IL-8 production by cultures stimulated with these pathogens as well as unstimulated cells but only at the highest concentration (10,000 ng/mL) tested (Figure 1 ). At this concentration, P 4 also significantly reduced the number of viable cells for unstimulated cultures (P-0.001) as well as those treated with E. coli (P-0.001), G. vaginalis (P-0.001) or U. urealyticum (P-0.001).
Results
Vaginal epithelial cells
Endocervical cells
IL-8 production by endocervical cells was slightly enhanced by stimulation with E. coli (2129 .34"88.10 vs. 2946 control vs. treated; Ps0.0286), G. vaginalis (2296.85"120.74 vs. 5378.50"120.74 pg/mL; Ps0.0154), or U. urealyticum (1920.23"166.43 vs. 3288.87"166 .43 pg/mL; Ps0.0668). Both basal and bacteria-stimulated IL-8 production was enhanced by P 4 in a dose-dependent manner, however, results were only significant for cultures treated with very high doses of 1000 and 10,000 pg/mL P 4 ( Figure 2 ). As with vaginal epithelial cells, the number of viable cells was reduced by 1000-10,000 pg/mL P 4 (Figure 2 ).
Discussion
We found that E. coli, G. vaginalis and U. urealyticum increase the production of IL-8 by both vaginal and cervical epithelial cells. This is consistent with previous studies which reported that Neisseria gonorrhoeae induce the 8 CFU/mL heat-killed E. coli for, 2=10 6 CFU/mL G. vaginalis or 11 CCU of U. urealyticum or an equivalent volume of sterile medium (unstimulated cells) in separate experiments. Shown are least-squares means"SEM for IL-8 production (left panels) and relative number of viable cells as determined by the MTT assay (right panels). Points marked with an asterisk(s) are significantly different from 0 ng/mL P 4 for that bacterial treatment (*P-0.05; **P-0.01; ***P-0.0001). production of proinflammatory chemokines by these cell lines w12x. Clinical studies have also shown an association with increased IL-8 levels in vaginal lavage of women with genital mycoplasmas compared with normal flora w28x. IL-8 levels in vaginal fluid are also positively correlated with concentrations of IgA to G. vaginalis hemolysin w2x which is consistent with our results.
In general, we found that P 4 significantly decreased bacteria-stimulated IL-8 production by vaginal epithelial cells for all pathogens studied as well as for cultures not treated with bacteria. This immunosuppressive effect is consistent with the observation that progesterone enhances the establishment of infections with Mycoplasma pulmonis w15x, M. pneumoniae w14, 15x, M. genitalium w15x, Chlamydia w20x and herpes simplex virus w16x in animal models. Part of the mechanism for P 4 -immunomodulation of bacteria-stimulated IL-8 production may involve effects on viability or proliferation of the vaginal epithelial cells. High concentrations of P 4 consistently lowered the number of viable vaginal epithelial cells regardless of whether or not pathogens were present. This is consistent with previous studies that reported Previous studies demonstrated that P 4 can suppress IL-8 production in the rabbit cervix w18x, therefore, we hypothesized that high concentrations of P 4 may block bacteria-stimulated increases in IL-8 production that, in turn, may prevent premature cervical ripening and its consequences, including preterm birth. Contrary to our expectation, however, we found that P 4 increases basal and bacteria-stimulated production of IL-8 by endocervical cells. These results differ from those of a previous report where P 4 had no effect on basal or phorbol esterstimulated IL-8 production by cervical explants from nonpregnant women w1x. The difference between these results may be due to the concentrations of P 4 used to treat the cultures. Barclay et al. used 1 mM P 4 which is equivalent to 314.5 ng/mL. We tested P 4 at concentrations of up to 10,000 ng/mL which were supraphysiological because concentrations in the term placenta are only about 2000-3000 ng/g tissue w21x. It is likely however, that the concentration used in our in vitro study are still lower than what would be present in the lower genital tract after intravaginal placement of 90-200 mg P 4 as was done in the two protocols demonstrating P 4 's effectiveness at preventing preterm birth in women with a short cervix w7, 13x.
Although we found that high levels of P 4 enhance rather than inhibit IL-8 production in the cervix, recent evidence suggests that a small increase in IL-8 could be beneficial in preventing preterm birth. Asymptomatic women who later go on to develop intra-amniotic infection had lower levels of IL-8, IL-1b and IL-6 in the cervix compared to women who did not w27x. It is proposed that the lower levels of cytokines resulted in hypo-responsiveness to bacteria and enabled infections to become more easily established in the cervix and to ascend into the upper genital tract w27x. A slight enhancement of IL-8 production and perhaps other proinflammatory mediators by P 4 in the cervix may help to clear infections before they become established in the cervix and trigger a much more robust IL-8 response that causes a massive host response that results in cervical ripening and preterm birth.
Our finding that P 4 decreased the number of viable endocervical cells suggests that augmentation of IL-8 levels is not due to any proliferative effect of P 4 on the cells. Although fewer endocervical cells are present in P 4 -treated cultures, it is likely that they could still produce more IL-8 upon stimulation with bacteria if IL-8 production in each cell was increased enough to compensate for the 20% fewer live cells that are present. Although it is possible that high concentrations of P 4 are toxic to cells, it is more likely that this hormone reduces their proliferation. A previous study reported that injection of medroxyprogesterone decreases DNA synthesis in the rabbit endocervix w3x. P 4 may do this by lowering the expression of the epithelial growth factor receptor on endocervical cells w4x. A small amount (0.1 ng/mL) of epidermal growth factor in the medium is required for the cultivation of these cells w11x and P 4 -mediated reductions in the EGF receptor may inhibit the proliferation of these cells as well.
Although a number of other cytokines are increased during cervical ripening, we chose to focus on IL-8 for several reasons. First, our preliminary studies demonstrated that the cell lines responded most robustly to bacterial stimulation with this cytokine. Second, IL-8 is a chemoattractant and activator of neutrophils which are recruited to the cervix during ripening. IL-8 levels are positively correlated with granulocyte elastase levels in the cervix w26x. Third, placement of IL-8 into the cervix causes ripening in animal models w5, 9x. Although other proinflammatory cytokines such as TNF-a and IL-1b are increased in the cervix during cervical ripening, these cytokines also induce the production of IL-8 by endocervical cells w9x. Therefore, their biological activity for promoting cervical ripening may be mediated, at least in part, through IL-8 production. Genetic knock-out mice for many proinflammatory cytokines such as IL-1b, TNFa, and MCP-1 are available and we are unaware of any defects in cervical ripening in such animals. Therefore, we chose to study IL-8 as a model cytokine for the hostimmune response, and to test variety of species of bacteria containing different virulence factors rather than a variety of cytokines and chemokines that would be highly correlated with one another.
Our results are also limited by several factors that are inherent to in vitro experiments with transformed cell lines. For example, we are unable to account for the impact that other maternal or fetal hormones or cell types in the lower genital tract may have had on the ability for P 4 to modulate IL-8 concentrations in the cervix or the vagina. We are also unable to determine what exposure to P 4 over the course of many weeks may have on the responsiveness of cells to bacteria. Furthermore, immune responses to a live, growing culture of bacteria in vivo may be markedly different from those generated by stimulation of cells with heat-killed organisms. These limitations could partially be overcome by quantifying cervical levels of IL-8, and bacteria in clinical samples from women taking supplemental progesterone. It would be very difficult now, however, to get samples from a control group with similar reproductive histories since the use of this hormone for preventing preterm birth is now widespread. It would also be difficult to interpret how cervical cytokines respond to bacterial pathogens in women in vivo when the vaginal flora is complex and consists of many different species. In contrast, our study with transformed cells enabled to study many different treatments under carefully controlled conditions with human cells which would not be possible in a clinical setting.
